Nuritas is a company revolutionizing the discovery of novel and natural active ingredients with scientifically proven health benefits. Our disruptive approach to discovery combines artificial intelligence and DNA analysis to data-mine billions of molecules. This means that for the first time Nuritas can rapidly and efficiently provide access to the most health-benefiting components within foods, called bioactive peptides. Our life-changing peptides, the subject of pending patent applications, provide unique solutions for the maintenance of health and wellness. These benefits include: anti-inflammatory activity, antimicrobial activity, muscle recovery enhancement, skin anti-aging solutions, and the potential management of blood sugar levels for type 2 diabetics. Put in a nutshell, the company discovers and unlocks ingredients from food sources in a completely unique way, providing natural, sustainable and scientifically proven health solutions. Our dynamic peptides have a vast range of applications in multiple industries including functional and medical foods, pharmaceuticals, dietary supplements, and cosmetics and personal care.
Company Growth (employees)
Type
Private
HQ
Dublin, IE
Founded
2014
Size (employees)
31 (est)+15%
Nuritas was founded in 2014 and is headquartered in Dublin, IE

Key People/Management at Nuritas

Emmet Browne

Emmet Browne

CEO
Greg Staffor

Greg Staffor

CFO
Nora Khaldi

Nora Khaldi

Founder and CSO

Nuritas Office Locations

Nuritas has an office in Dublin
Dublin, IE (HQ)
Cumberland St S Westland Ct
Show all (1)

Nuritas Financials and Metrics

Summary Metrics

Founding Date

2014

Total Funding

$27.4 m

Latest funding size

$18.9 m

Time since last funding

30 days

Investors

Nuritas's latest funding round in December 2017 was reported to be $18.9 m. In total, Nuritas has raised $27.4 m

Nuritas's Web-traffic and Trends

Nuritas Online and Social Media Presence

Nuritas News and Updates

Dutch biotech company Nuritas lands $20 mln Series A

Dublin-based biotech company Nuritas has raised $20 million in Series A funding. Cultivian Sandbox Ventures led the round.

Irish biotech company Nuritas lands $20 mln Series A

Irish biotech company Nuritas has raised $20 million in Series A funding. Cultivian Sandbox Ventures led the round.

Biotech startup Nuritas raises €16 million in Series A funding

Nuritas, an Irish biotech startup, has raised €16 million in a Series A round led by US firm Cultivian Sandbox Ventures. Nuritas has built a medical platform that uses artificial intelligence to analyse peptides in food, which it claims is 500 times faster than current technology. “Our artificial in…

Nuritas Company Life and Culture

You may also be interested in